| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.
|
N Engl J Med
|
2009
|
13.42
|
|
2
|
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
|
Lancet
|
2015
|
3.87
|
|
3
|
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.
|
J Am Coll Cardiol
|
2010
|
2.89
|
|
4
|
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
|
JAMA
|
2008
|
2.39
|
|
5
|
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.
|
Lancet
|
2010
|
2.38
|
|
6
|
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
|
Eur Heart J
|
2011
|
2.32
|
|
7
|
Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
2.12
|
|
8
|
Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
|
J Am Coll Cardiol
|
2009
|
2.12
|
|
9
|
Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart.
|
Regul Pept
|
2007
|
1.72
|
|
10
|
Restenosis in coronary bare metal stents. Importance of time to follow-up: a comparison of coronary angiograms 6 months and 4 years after implantation.
|
Scand Cardiovasc J
|
2009
|
1.39
|
|
11
|
When operable patients become inoperable: conversion of a surgical aortic valve replacement into transcatheter aortic valve implantation.
|
Interact Cardiovasc Thorac Surg
|
2009
|
1.38
|
|
12
|
Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
|
Am Heart J
|
2006
|
1.38
|
|
13
|
Selective use of contemporary drug-eluting stents in primary angioplasty for ST-elevation myocardial infarction: pooled analysis of COMFORTABLE AMI and EXAMINATION.
|
EuroIntervention
|
2017
|
1.37
|
|
14
|
A novel prehospital electrocardiogram score predicts myocardial salvage in patients with ST-segment elevation myocardial infarction evaluated by cardiac magnetic resonance.
|
Cardiology
|
2013
|
1.37
|
|
15
|
Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.
|
Circ Cardiovasc Interv
|
2010
|
1.30
|
|
16
|
Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.
|
Ann Intern Med
|
2013
|
1.24
|
|
17
|
Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
|
J Am Coll Cardiol
|
2008
|
1.12
|
|
18
|
Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.
|
Circ Cardiovasc Interv
|
2012
|
1.10
|
|
19
|
Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.
|
J Am Coll Cardiol
|
2008
|
1.08
|
|
20
|
Prognostic importance of complete atrioventricular block complicating acute myocardial infarction.
|
Am J Cardiol
|
2003
|
1.04
|
|
21
|
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.
|
J Am Coll Cardiol
|
2010
|
1.04
|
|
22
|
Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial.
|
Circulation
|
2008
|
1.02
|
|
23
|
Correlation between coronary computed tomographic angiography and fractional flow reserve.
|
Int J Cardiol
|
2009
|
0.98
|
|
24
|
The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart.
|
Pharmacol Res
|
2009
|
0.94
|
|
25
|
Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study.
|
EuroIntervention
|
2013
|
0.89
|
|
26
|
Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols.
|
J Cardiovasc Magn Reson
|
2011
|
0.89
|
|
27
|
Influence of pre-infarction angina, collateral flow, and pre-procedural TIMI flow on myocardial salvage index by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction.
|
Eur Heart J Cardiovasc Imaging
|
2011
|
0.88
|
|
28
|
Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.88
|
|
29
|
Transcatheter valve-in-valve implantation due to severe aortic regurgitation in a degenerated aortic homograft.
|
J Invasive Cardiol
|
2009
|
0.87
|
|
30
|
ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance.
|
Am Heart J
|
2010
|
0.86
|
|
31
|
Automated assessment of heart chamber volumes and function in patients with previous myocardial infarction using multidetector computed tomography.
|
J Cardiovasc Comput Tomogr
|
2012
|
0.84
|
|
32
|
Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.
|
Am J Cardiol
|
2011
|
0.84
|
|
33
|
Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction.
|
Am Heart J
|
2012
|
0.83
|
|
34
|
Comparison of Selvester QRS score with magnetic resonance imaging measured infarct size in patients with ST elevation myocardial infarction.
|
J Electrocardiol
|
2012
|
0.83
|
|
35
|
Assessment of left atrial volume and function: a comparative study between echocardiography, magnetic resonance imaging and multi slice computed tomography.
|
Int J Cardiovasc Imaging
|
2011
|
0.82
|
|
36
|
Cardiac symptoms before sudden cardiac death caused by coronary artery disease: a nationwide study among young Danish people.
|
Heart
|
2013
|
0.82
|
|
37
|
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
|
JACC Cardiovasc Interv
|
2013
|
0.81
|
|
38
|
Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
|
Eur Heart J
|
2015
|
0.81
|
|
39
|
Left atrial and ventricular function during dobutamine and glycopyrrolate stress in healthy young and elderly as evaluated by cardiac magnetic resonance.
|
Am J Physiol Heart Circ Physiol
|
2012
|
0.80
|
|
40
|
The decrease of cardiac chamber volumes and output during positive-pressure ventilation.
|
Am J Physiol Heart Circ Physiol
|
2013
|
0.78
|
|
41
|
Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome.
|
Platelets
|
2014
|
0.78
|
|
42
|
Transcatheter aortic valve prosthesis surgically replaced 4 months after implantation.
|
Eur J Cardiothorac Surg
|
2009
|
0.78
|
|
43
|
Glucagon-like peptide 1--a cardiologic dimension.
|
Trends Cardiovasc Med
|
2010
|
0.78
|
|
44
|
Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging.
|
Int J Cardiovasc Imaging
|
2011
|
0.77
|
|
45
|
[Percutaneous aortic valve replacement - initial experience and results].
|
Ugeskr Laeger
|
2009
|
0.77
|
|
46
|
Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction.
|
Am J Cardiol
|
2009
|
0.77
|
|
47
|
Postconditioning with curaglutide, a novel GLP-1 analog, protects against heart ischemia-reperfusion injury in an isolated rat heart.
|
Regul Pept
|
2012
|
0.77
|
|
48
|
Measurements of pericardial adipose tissue using contrast enhanced cardiac multidetector computed tomography--comparison with cardiac magnetic resonance imaging.
|
Int J Cardiovasc Imaging
|
2013
|
0.77
|
|
49
|
Increased myocardial vulnerability to ischemia-reperfusion injury in the presence of left ventricular hypertrophy.
|
J Hypertens
|
2016
|
0.76
|
|
50
|
Conditioning techniques and ischemic reperfusion injury in relation to on-pump cardiac surgery.
|
Scand Cardiovasc J
|
2014
|
0.75
|
|
51
|
ST peak during primary percutaneous coronary intervention predicts final infarct size, left ventricular function, and clinical outcome.
|
J Electrocardiol
|
2012
|
0.75
|
|
52
|
Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response--the TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial.
|
Platelets
|
2013
|
0.75
|
|
53
|
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy).
|
BMC Cardiovasc Disord
|
2012
|
0.75
|
|
54
|
Correlating infarct size and patient prognosis: are cardiac biomarkers truly insufficient? Reply.
|
Eur Heart J Cardiovasc Imaging
|
2013
|
0.75
|
|
55
|
Left atrial passive emptying function is preserved in patients with permanent atrial fibrillation--a 320-slice multidetector computed tomography study.
|
Cardiology
|
2014
|
0.75
|
|
56
|
The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction.
|
EuroIntervention
|
2017
|
0.75
|
|
57
|
Determining the optimal time to introduce ischemic postconditioning.
|
Expert Rev Cardiovasc Ther
|
2011
|
0.75
|
|
58
|
[Percutaneous assist device during acute heart failure].
|
Ugeskr Laeger
|
2007
|
0.75
|
|
59
|
[A new percutan assist device for treatment of fulminant myocarditis].
|
Ugeskr Laeger
|
2007
|
0.75
|
|
60
|
To defer, or not to defer, that is the question.
|
EuroIntervention
|
2017
|
0.75
|
|
61
|
Reply: Deferred Stenting in STEMI: Still an Interest in Selected Patients?
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
62
|
Intravenous beta-blocker therapy in ST-Segment Elevation Myocardial Infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: A Swedish Nationwide Observational Study.
|
EuroIntervention
|
2017
|
0.75
|
|
63
|
Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis.
|
EuroIntervention
|
2016
|
0.75
|
|
64
|
Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: an observational comparative study.
|
Thromb Haemost
|
2015
|
0.75
|
|
65
|
[Glucagon-like peptide-1: a cardiological perspective].
|
Ugeskr Laeger
|
2010
|
0.75
|
|
66
|
Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to "mega centre" for patients with ST-segment elevation myocardial infarction.
|
EuroIntervention
|
2015
|
0.75
|
|
67
|
A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction.
|
EuroIntervention
|
2016
|
0.75
|
|
68
|
[Transcatheter replacement of the aortic valve--a novel treatment modality for high-risk patients].
|
Ugeskr Laeger
|
2009
|
0.75
|
|
69
|
Termination of dobutamine infusion causes transient rebound left heart diastolic dysfunction in healthy elderly women but not in men: a cardiac magnetic resonance study.
|
Am J Physiol Heart Circ Physiol
|
2013
|
0.75
|
|
70
|
ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial.
|
EuroIntervention
|
2014
|
0.75
|
|
71
|
Bleeding episodes in "complete, staged" versus "culprit only" revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy.
|
EuroIntervention
|
2016
|
0.75
|